1. Home
  2. CTRE vs TECH Comparison

CTRE vs TECH Comparison

Compare CTRE & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareTrust REIT Inc.

CTRE

CareTrust REIT Inc.

N/A

Current Price

$39.40

Market Cap

9.9B

Sector

Real Estate

ML Signal

N/A

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

N/A

Current Price

$72.33

Market Cap

11.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTRE
TECH
Founded
2013
1976
Country
United States
United States
Employees
N/A
3000
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
11.4B
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
CTRE
TECH
Price
$39.40
$72.33
Analyst Decision
Buy
Strong Buy
Analyst Count
10
11
Target Price
$42.40
$71.82
AVG Volume (30 Days)
1.8M
2.3M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
3.44%
0.62%
EPS Growth
96.25
152.17
EPS
0.74
1.16
Revenue
$476,393,000.00
$1,215,039,000.00
Revenue This Year
$5.97
$2.49
Revenue Next Year
$13.39
$6.40
P/E Ratio
$52.72
$62.44
Revenue Growth
60.79
N/A
52 Week Low
$32.79
$43.20
52 Week High
$43.62
$72.62

Technical Indicators

Market Signals
Indicator
CTRE
TECH
Relative Strength Index (RSI) 45.53 62.80
Support Level $38.31 $71.89
Resistance Level $40.12 $72.37
Average True Range (ATR) 0.70 0.15
MACD 0.02 -0.17
Stochastic Oscillator 52.61 50.60

Price Performance

Historical Comparison
CTRE
TECH

About CTRE CareTrust REIT Inc.

CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: